2.70 USD
↘ 0.06 (2.17%)AT CLOSE (11:59 AM EDT)
AC Immune SA
ACIUNASDAQ • USD
2.71
↗ 0.02 (0.70%)
POST MARKET (AS OF 05:21 PM EDT)
Post Market
AS OF 05:21 PM EDT
2.71
↗ 0.02 (0.70%)
Market: OPEN
Open?$2.78
High?$2.85
Low?$2.65
Prev. Close?$2.76
Volume?169.9K
Avg. Volume?N/A
VWAP?$2.72
Bid / Ask
Bid?$2.70 × 100
Ask?$2.71 × 200
Spread?$0.01
Midpoint?$2.71
Valuation & Ratios
Market Cap?280.9M
Shares Out?101.8M
Float?62.7M
Float %?61.6%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.